Cargando…
HDAd5/35(++) Adenovirus Vector Expressing Anti-CRISPR Peptides Decreases CRISPR/Cas9 Toxicity in Human Hematopoietic Stem Cells
We generated helper-dependent HDAd5/35(++) adenovirus vectors expressing CRISPR/Cas9 for potential hematopoietic stem cells (HSCs) gene therapy of β-thalassemia and sickle cell disease through re-activation of fetal γ-globin expression (HDAd-globin-CRISPR). The process of CRISPR/Cas9 gene transfer u...
Autores principales: | Li, Chang, Psatha, Nikoletta, Gil, Sucheol, Wang, Hongjie, Papayannopoulou, Thalia, Lieber, André |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054697/ https://www.ncbi.nlm.nih.gov/pubmed/30038942 http://dx.doi.org/10.1016/j.omtm.2018.04.008 |
Ejemplares similares
-
Integrating HDAd5/35++ Vectors as a New Platform for HSC Gene Therapy of Hemoglobinopathies
por: Li, Chang, et al.
Publicado: (2018) -
Safe and efficient in vivo hematopoietic stem cell transduction in nonhuman primates using HDAd5/35++ vectors
por: Li, Chang, et al.
Publicado: (2021) -
In vivo HSC transduction in rhesus macaques with an HDAd5/3+ vector targeting desmoglein 2 and transiently overexpressing cxcr4
por: Wang, Hongjie, et al.
Publicado: (2022) -
Novel HDAd/EBV Reprogramming Vector and Highly Efficient Ad/CRISPR-Cas Sickle Cell Disease Gene Correction
por: Li, Chao, et al.
Publicado: (2016) -
Brief Report: A Differential Transcriptomic Profile of Ex Vivo Expanded Adult Human Hematopoietic Stem Cells Empowers Them for Engraftment Better than Their Surface Phenotype
por: Psatha, Nikoletta, et al.
Publicado: (2017)